 Human strongyloidiasis is widely prevalent in tropical and subtropical regions worldwide but is not endemic in Hawaii. Subclinical , chronic<disease> infections<disease> may be lifelong; immunosuppressive therapy , particularly with glucocorticoids , may lead to serious or fatal disseminated disease , which is preventable. We performed a retrospective analysis of patients tested for